Katherine Kunkel, MD
Interventional Cardiology · Atlanta, GANPI 1538502562
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $118,150 of the $188,690 with a category attached, or 62.6%. 28 manufacturers reported payments, led by Abiomed at 40.7% of the total. Reporting peaked in 2023 at $72,401 and has fallen 78.6% since, to $15,486 in 2025. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 293 payments — averaging $643.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$77K
- Medtronic$53K
- Boston Scientific$22K
- Cardiovascular Systems Inc.$16K
- Abbott$8K
- Shockwave Medical, Inc$5K
- plus $8K from 22 others
Across 16 payments — averaging $4573.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- M.a. Med Alliance S.A.$38K
- Shockwave Medical, Inc$33K
- Medalliance LLC$2K
What the payments were for
- Consulting fees$16,4589%
- Speaking & faculty fees$118,15063%
- Grants$20,00011%
- Travel & lodging$24,53813%
- Food & beverage$9,3665%
- Education$1780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 36 | $76,704 |
| Medtronic(2 entities) | 86 | $52,637 |
| Boston Scientific | 21 | $22,053 |
| Cardiovascular Systems Inc. | 23 | $16,438 |
| Abbott | 20 | $7,976 |
| Shockwave Medical, Inc | 16 | $4,685 |
| Biotronik Inc. | 4 | $2,383 |
| Janssen Global Services, LLC | 1 | $2,020 |
| Novartis | 39 | $665 |
| Edwards Lifesciences | 9 | $614 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $568 |
| AstraZeneca | 5 | $440 |
| Teleflex LLC | 3 | $338 |
| ZOLL Circulation Inc | 3 | $274 |
| Angiodynamics, Inc. | 3 | $182 |
| Bard Peripheral Vascular, Inc. | 1 | $150 |
| Siemens Medical Solutions USA, Inc. | 1 | $120 |
| Amgen | 2 | $110 |
| Philips North America LLC | 1 | $74 |
| W. L. Gore & Associates, Inc. | 1 | $66 |
| Asahi Intecc USA, Inc. | 2 | $44 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Cardiva Medical, Inc. | 1 | $26 |
| Heartflow, Inc. | 1 | $20 |
| Pfizer | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Cordis US CORP. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$76,389
- Diamondback Coronary$21,584
- SYMPLICITY G3$20,878
- GENERAL ATHERECTOMY$20,000
- RESOLUTE ONYX$7,481
- Diamondback Peripheral$6,831
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$4,266
- PK Papyrus$2,275
- CoreValve Evolut$1,464
- Resolute$965
- GENERAL - THERAPIES$938
- GUIDELINER$248
- ONYX FRONTIER$153
- GENERAL VASCULAR ACCESS$150
- Integrity$140
- CROSSBOSS$140
- Vascular Lithotripsy$135
- STINGRAY$128
- Edwards SAPIEN 3 Transcatheter Heart Valve$126
- BRILINTA$126
How this compares
$188,690 in reported general payments places this provider in the 95th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $31,941 |
| EntrestoSacubitril/Valsartan | 26 | $21,980 |
| JardianceEmpagliflozin | 15 | $21,698 |
| Rosuvastatin Calcium | 102 | $1,636 |
| ClopidogrelClopidogrel Bisulfate | 158 | $1,599 |
| Ezetimibe | 35 | $878 |
| Metoprolol Succinate | 93 | $877 |
| Atorvastatin Calcium | 90 | $557 |
| Losartan Potassium | 59 | $390 |
| Spironolactone | 40 | $390 |
| Prasugrel Hcl | 17 | $376 |
| Isosorbide Dinitrate | 11 | $321 |
| Hydralazine Hcl | 29 | $215 |
| Olmesartan Medoxomil | 12 | $197 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 15 | $161 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $20 | $31,94126 claims |
| NovartisEntresto | $665 | $21,98026 claims |
| Boehringer IngelheimJardiance | $16 | $21,69815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 218 interventional cardiology providers in Georgia.
Other interventional cardiology in Atlanta
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Adam GreenbaumAtlanta$238K
- Wissam JaberAtlanta$222K
- James StewartAtlanta$174K
- Pratik SandesaraAtlanta$165K
- Chandanreddy DevireddyAtlanta$121K
- Prashant KaulAtlanta$109K
- Nikoloz ShekiladzeAtlanta$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.